Research aims to improve interstitial lung disease prognosis with new imaging agent
Researchers at the University of Exeter and clinical radiopharmaceutical company Serac Healthcare Ltd are researching a new molecular imaging marker...
Researchers at the University of Exeter and clinical radiopharmaceutical company Serac Healthcare Ltd are researching a new molecular imaging marker...
LONDON, Sept. 10, 2024 /PRNewswire/ -- Serac Healthcare Limited ("Serac Healthcare" or "the Company"), a clinical radiopharmaceutical company developing innovative...
Coming as part of a collaboration with pharmaceutical giant Johnson & Johnson, the multi-centre trial aims to test Invenio’s NIO...
Speaking at Hospital Healthcare Europe’s Clinical Excellence in Respiratory Care event, our panel of three respiratory experts considered the use...
The FDA clearance follows after a phase II tralokinumab clinical trial published in the American Journal of Respiratory and Critical...
The “rise of the machines” has played a critical role in advancing medical research and improving accuracy of diagnostic precision...